x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAB-0012205
| Product Information | |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG |
| Host Species | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Applications | WB, IP |
| Product Description | Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala382 of human ITPK1 protein. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | ITPK1 |
| UniProt No. | Q13572 |
| Gene ID | 3705 |
| Gene Description | Inositol phosphates are key second messengers produced from receptor activated phospholipase c isoforms as well as a family of inositol kinases including ITPK1, IPMK, IPK1, IP3K, IP6K, and VIP1. Lipid-derived inositol 1, 3, 4-trisphosphate P3) produced from PLC is a well known regulator of calcium signaling. Cytosolic InsP3 is further modified to higher order IPs and pyrophosphates with roles in numerous physiological processes, including energy metabolism, ion channel regulation, transcriptional regulation, and cell death.ITPK1 is a reversible, poly-specific IP kinase that phosphorylates InsP3 with potential physiological implications including acting as a modifier of cystic fibrosis. ITPK1 can add either a 5- or 6-phosphate to InsP3, add a 1-phosphate to InsP4, or dephosphorylate InsP5 to InsP4. ITPK1 inhibits TNF-alpha induced cell death, though the mechanism is unclear. ITPK1 as well as IPMK were associated with essential roles in MLKL-dependent necroptosis, a programmed process for necrotic cell death. MLKL directly interacts with higher order IPs like IP6, and is important for oligomerization of phosphorylated MLKL and subsequent plasma membrane localization. Mice generated with reduced expression of ITPK1 have neural tube defects. Furthermore, polymorphisms in the maternal ITPK1 gene have been associated as risk factors for neural tube defects resulting in spina bifida. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
| Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
